...
首页> 外文期刊>PLoS One >Physicians communicating with women at genetic risk of breast and ovarian cancer: Are we in the middle of the ford between contradictory messages and unshared decision making?
【24h】

Physicians communicating with women at genetic risk of breast and ovarian cancer: Are we in the middle of the ford between contradictory messages and unshared decision making?

机译:医生与乳腺癌和卵巢癌的遗传风险沟通的医生:我们是在福特之间的矛盾消息和非共享决策之间的中间吗?

获取原文
   

获取外文期刊封面封底 >>

       

摘要

BRCA1/2 genetic testing offers tremendous opportunities for prevention, diagnosis and treatment of breast and ovarian cancer. Women acquire valuable information that can help them to make informed decisions about their health. However, knowing one’s susceptibility to developing cancer may be burdensome for several women, as this risk needs to be managed over time through a continuous dialogue with multiple healthcare professionals. We explored how communication between physicians and unaffected women carrying BRCA1/2 germline pathogenic variants was experienced by women in relation to their genetic risk. Data came from qualitative interviews conducted in Switzerland with 32 unaffected women carrying BRCA1/2 pathogenic variants and aware of their genetic status for at least 3 years. We identified three different types of message as conveyed by physicians to women: (1) a normative message, (2) an over-empowering message, and (3) a minimizing message. On one hand, we found that women are exposed to contradictory messages, often simultaneously, in their interactions with healthcare professionals during their post-genetic testing journey. On the other hand, women’s reports highlighted the absence of shared decision-making in such interactions. The combination of these two findings resulted in a strong sense of disorientation, frustration, and powerlessness among participants. Healthcare professionals interacting with high cancer risk women are urged to align in favor of a both concerted and shared decision-making approach when discussing options for managing genetic risk.
机译:BRCA1 / 2基因检测为乳腺癌和卵巢癌的预防,诊断和治疗提供了巨大的机会。妇女获得有价值的信息,可以帮助他们向他们的健康做出明智的决定。然而,了解一个人对发展癌症的易感性可能是几个女性的繁重,因为这种风险需要随着多次医疗专业人士的连续对话而随着时间的推移进行管理。我们探讨了医生和携带BRCA1 / 2种系致病变异的不受影响的女性之间的通信是如何经受遗传风险的。数据来自瑞士在瑞士进行的定性访谈,32名未受影响的女性携带BRCA1 / 2致病变种,并意识到其遗传地位至少3年。我们确定了由医生传达给女性的三种不同类型的信息:(1)规范信息,(2)过度赋予的消息,(3)最小化消息。一方面,我们发现妇女在其后遗传测试之旅期间与医疗保健专业人员的互动接触到矛盾的信息。另一方面,妇女报告强调了这种互动中没有共享决策。这两个结果的组合导致参与者之间强烈的迷失方识,挫折和无能为力。敦促医疗保健专业人士与高癌症风险妇女进行互动,以便在讨论管理遗传风险的选项时,有利于协调一致和共同的决策方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号